Navigation Links
Luminex Corporation Reports Second Quarter 2011 Results
Date:8/8/2011

OF CASH FLOWS(in thousands)Three Months EndedSix Months EndedJune 30,June 30,2011201020112010(unaudited)(unaudited)Cash flows from operating activities:Net income

$
4,643$
884$
9,104$
2,759Adjustments to reconcile net income to net cash provided by operating activities:Depreciation and amortization

2,6222,1215,1384,284Stock-based compensation

2,9932,4395,5404,606Deferred income tax benefit

2,0549113,3792,505Excess income tax benefit from employee stock-based awards

(1,501)(1,524)(3,705)(1,524)Other

234(72)305263Changes in operating assets and liabilities:Accounts receivable, net

68(1,042)6,6565,210Inventories, net

1,793(547)1,207(2,113)Other assets

(164)(818)(1,186)(745)Accounts payable

(1,510)721(4,254)(3,466)Accrued liabilities

1,9532,038167(1,345)Deferred revenue

(317)(37)(460)740Net cash provided by operating activities

12,8685,07421,89111,174Cash flows from investing activities:Purchases of available-for-sale securities

(22,201)(9,054)(29,247)(21,667)Maturities of available-for-sale securities

7,25612,99814,17716,193Purchase of property and equipment

(2,644)(3,985)(3,798)(5,449)Business acquisition consideration, net of cash acquired

(33,914)(5,036)(33,914)(5,036)Increase in restricted cash

-(1,000)-(1,000)Purchase of cost method investment

-(2,000)(2,000)(2,000)Acquired technology rights

(87)(1,200)(87)(1,200)Net cash used in investing activities

(51,590)(9,277)(54,869)(20,159)Cash flows from financing activities:Payments on debt

(885)(895)(885)(895)Proceeds from issuance of common stock

5903018181,440Payments for stock repurchases

(1,436)-(4,686)-Excess income tax benefit from employee stock-based awards

1,5011,5243,7051,524Net cash (used in) provided by financing activities

(230)930(1,048)2,069Effect of foreign currency exchange rate on cash

18614959Change in c
'/>"/>

SOURCE Luminex Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Luminex Corporation Receives U.S. FDA Clearance for New, Front Line Respiratory Viral Panel Test
2. Luminex Corporation Second Quarter Earnings Release Scheduled for August 8, 2011
3. Luminex Corporation Completes Acquisition of EraGen Biosciences, Inc.
4. Luminex Corporation Named Most Innovative Company of the Year and Receives Business Innovation of the Year Award for MAGPIX® System
5. Luminex Corporation Announces Agreement to Acquire EraGen Biosciences, Inc.
6. Luminex and Life Technologies Sign Agreement for Global Distribution of the Award-Winning MAGPIX® Multiplexing Instrument
7. Luminex Corporation to Present at Jefferies 2011 Global Healthcare Conference
8. Luminex Corporation Reports First Quarter 2011 Results
9. Luminex Corporation First Quarter Earnings Release Scheduled for May 9, 2011
10. Luminex Corporation Wins Prestigious Medical Design Excellence Award
11. Luminex Corporation to Present at Cowen and Companys 31st Annual Health Care Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... Sihuan Pharmaceutical Holdings Group Ltd. (HKEx: ... pharmaceutical company with the largest cardio-cerebral vascular ("CCV") ... prescription drug market, today announced the unaudited consolidated ... the "Group") for the six months ended 30 ... the Six months ended 30 JuneKey Income Statement ...
(Date:8/27/2014)... N.C. , Aug. 27, 2014 Kewaunee ... its Board of Directors increased its quarterly cash dividend ... eleven cents per outstanding share, beginning with the dividend ... at the close of business on September 8, 2014. ... Founded in 1906, Kewaunee Scientific Corporation is a ...
(Date:8/27/2014)... THOUSAND OAKS, Calif. , Aug. 27, 2014 /PRNewswire/ ... the U.S. Food and Drug Administration (FDA) has granted ... chronic heart failure (HF). Ivabradine is an oral drug ... ("funny" current) in the sinoatrial node, the body,s cardiac ... rate without negative effects on myocardial contractility or ventricular ...
Breaking Medicine Technology:Sihuan Pharmaceutical Announces 2014 Interim Results 2Sihuan Pharmaceutical Announces 2014 Interim Results 3Sihuan Pharmaceutical Announces 2014 Interim Results 4Sihuan Pharmaceutical Announces 2014 Interim Results 5Sihuan Pharmaceutical Announces 2014 Interim Results 6Sihuan Pharmaceutical Announces 2014 Interim Results 7FDA Grants Amgen Priority Review Designation For Ivabradine For The Treatment Of Chronic Heart Failure 2FDA Grants Amgen Priority Review Designation For Ivabradine For The Treatment Of Chronic Heart Failure 3FDA Grants Amgen Priority Review Designation For Ivabradine For The Treatment Of Chronic Heart Failure 4FDA Grants Amgen Priority Review Designation For Ivabradine For The Treatment Of Chronic Heart Failure 5FDA Grants Amgen Priority Review Designation For Ivabradine For The Treatment Of Chronic Heart Failure 6FDA Grants Amgen Priority Review Designation For Ivabradine For The Treatment Of Chronic Heart Failure 7
... 20, 2011 Chembio Diagnostics, Inc. (OTC/QB: CEMI & ... diagnostic tests, announced today that the Company will release ... the open of the market on Thursday, November 3, ... be available immediately after 9:15 a.m. on our web ...
... Cardica, Inc. (Nasdaq: CRDC ) today announced that it ... 30, 2011, on Thursday, October 27, 2011, after the markets close. ... Time to discuss the financial results and provide an update on ... To access the live conference call on October 27, ...
Cached Medicine Technology:Chembio to Host Conference Call to Discuss 3rd Quarter 2011 Financial Results 2Chembio to Host Conference Call to Discuss 3rd Quarter 2011 Financial Results 3Cardica to Announce Fiscal 2012 First Quarter Financial Results on Thursday, October 27, 2011 2
(Date:8/27/2014)... (PRWEB) August 27, 2014 For nearly ... performances by the beloved mantra singers Deva Premal & ... Following the release of their latest album in May, ... down in twenty-two countries around the globe, including Russia, ... Argentina and across Europe. With a new album and ...
(Date:8/27/2014)... positive hospital blood culture samples are discarded every day ... skin germs instead of specific disease-causing bacteria. , ... clinicians may be able to use the resistance profiles ... patients with antibiotics appropriate to their ailment, Tel Aviv ... Alon of TAU,s Sackler Faculty of Medicine and the ...
(Date:8/27/2014)... (PRWEB) August 27, 2014 According ... Market Research "Ablation Technologies Market (Applications: Cardiovascular, Gynecology, ... Electrical, Ultrasound, Microwave, Cryotherapy) - Global Industry Analysis, ... 2020," the global ablation technologies market was valued ... estimated to reach a market worth USD 10,611 ...
(Date:8/27/2014)... and tested an advanced statistical model to evaluate ... disease as published yesterday in Human Genetics ... gap in current analyses. Complex diseases like cancer ... environmental factors. When many such combinations are studied, ... chance combinations among affected individuals becomes difficult. In ...
(Date:8/27/2014)... August 27, 2014 Nava Beauty Store and ... to all patrons from those seeking luxury care products to ... They carry high end luxurious brands like Valmont and Elemis ... also sells brands like Dermalogica and Bliss to provide easy ... customers. They also offer purely organic skin care products such ...
Breaking Medicine News(10 mins):Health News:Deva Premal & Miten's Mantras For Life Tour Announced 2Health News:Deva Premal & Miten's Mantras For Life Tour Announced 3Health News:'Junk' blood tests may offer life-saving information 2Health News:Global Ablation Technologies Market Expected to Reach USD 10.6 Billion in 2020: Transparency Market Research 2Health News:Global Ablation Technologies Market Expected to Reach USD 10.6 Billion in 2020: Transparency Market Research 3Health News:Global Ablation Technologies Market Expected to Reach USD 10.6 Billion in 2020: Transparency Market Research 4Health News:Global Ablation Technologies Market Expected to Reach USD 10.6 Billion in 2020: Transparency Market Research 5Health News:Dartmouth isolates environmental influences in genome-wide association studies 2Health News:Nava Beauty Store Announce Grand Opening in Great Neck, New York 2
... conducted among about 200 people with multiple sclerosis ( ... such as pain, tiredness,// emotional well-being, vitality, social functioning, ... living. Results from the MS patients were then compared ... the general population. ,Multiple sclerosis patients in the ...
... help doctors identify which postmenopausal women are at an ... most important// predictor of bone fracture in postmenopausal women ... mineral density is measured by a T-score. As the ... has been what level of a T-score indicates an ...
... standards for measuring blood pressure in children based on age, ... children as young as age 3 should receive regular blood ... percentile for blood pressure are diagnosed with high blood pressure. ... are said to have pre-hypertension -- a relatively new classification ...
... population carries a gene that puts them at risk for ... offspring.// Researchers say they already know one form of the ... to neural tube defects. They speculated another form of the ... ,Researchers studied about 400 people with neural tube defects, comparing ...
... 1 million cases of skin cancer are diagnosed. More than ... more than 7,000 people die yearly. Now, doctors are using ... some patients. ,Mary Louise Gramkow spent her life in ... sort of thing. [I am] just an outdoor person.” All ...
... worn by medical staff carry disease-causing bacteria. Researchers sampled ... and security personnel at a teaching hospital. Their data ... by the medical staff were contaminated with bacteria. ... transfer disease to patients, it is a good opportunity ...
Cached Medicine News:
... Littmann Electronic Stethoscope Model 4100WS features amplification ... allowing you to reduce ambient noise by ... critical body sounds. Three frequency modes are ... other body sounds: Bell (20-200 Hz), Diaphragm ...
... the best EMR value for many medical ... Charting Plus™ relies heavily on a user-friendly ... improve documentation quality and increase productivity in ... specific to your medical specialty. Each program ...
... is a portable, battery-powered bone growth stimulator used ... device is worn for 30 minutes each day ... fusion site. The device uses a unique technology, ... energy signal that is very potent in its ...
... is a multi-site, implantable biventricular ... and two ventricular ports for ... (AF) who have undergone an ... have NYHA Class II or ...
Medicine Products: